Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
NYU Langone Health
The objective of this study is to perform a pilot study, offering referral to a genetic counseling and genetic testing for family members of a probands known to have a mutation in BRCA1 or BRCA2. In addition to BRCA1 and BRCA2, the NCCN suggests consideration of risk-reducing surgery for mutations in BRIP1, MSH2, MLH1, MSH6, PMS2, EPCAM, RAD51C, RAD51D, investigators will include these subjects as well in the study.
Age
18–99
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
All subjects must have a diagnosis of epithelial ovarian cancer, Fallopian tube caner or primary peritoneal cancer with a known pathogenic genetic mutation.
All subjects must agree to participate.
All subjects must have first or second degree relatives who have not been diagnosed with the same genetic mutation.
A previous diagnosis of cancer in the subject's first or second degree relative is allowed.
You may not be if
Subjects whose first and/or second degree relatives have already been tested with the subject's known mutations, and no other viable family members are available for testing.